TLDR
- DuPont posted Q1 adjusted EPS of 55 cents, beating the 48-cent Wall Street estimate
- Net sales came in at $1.68 billion, slightly above the $1.67 billion consensus
- Full-year EPS guidance raised to $2.35–$2.40, up from $2.25–$2.30
- DuPont is launching a $275 million accelerated share repurchase “immediately”
- The company is pricing in ~1% to offset higher input costs tied to the Iran conflict
DuPont (DD) stock rose 1.6% to $46.15 in premarket trading Tuesday after the materials and chemicals company beat Q1 earnings estimates and lifted its full-year outlook.
Adjusted EPS came in at 55 cents, well ahead of the 48-cent consensus from FactSet. Net sales rose to $1.68 billion, from $1.61 billion a year earlier, and edged past the $1.67 billion estimate.
On a reported basis, DuPont swung to a profit of $161 million, or 39 cents a share, compared to a loss of $589 million, or $1.40 a share, in the same quarter last year.
$DD Q1 2026 earnings: The 'New DuPont' Shines: Margins Surge as Transformation Completes
DuPont's first quarter as a fully streamlined multi-industrial company delivered a clean beat-and-raise. With the Electronics spin-off and Aramids divestiture complete, the core portfolio… pic.twitter.com/N3fA6sedWT
— Finsee (@Finsee_main) May 5, 2026
It’s worth noting that prior-year figures aren’t a clean comparison. DuPont spun off its electronics business, Qnity Electronics, which affects the year-over-year numbers.
The Q1 results also include a three-cent-per-share contribution from discontinued operations related to the divestiture of its Aramids business, which closed April 1.
Guidance Gets a Lift
For the full year, DuPont now expects adjusted EPS of $2.35 to $2.40, up from the prior range of $2.25 to $2.30. Net sales guidance was raised to $7.16–$7.22 billion, from $7.08–$7.14 billion.
Both the new EPS and sales guidance sit above the current Wall Street consensus of $2.27 a share on $7.10 billion in sales.
For Q2, DuPont guided for adjusted EPS of around 59 cents on sales of about $1.8 billion. Analysts were expecting 58 cents on $1.8 billion, so that’s roughly in line.
CEO Lori Koch pointed to organic growth, margin expansion, and double-digit adjusted EPS growth as highlights of the quarter. CFO Antonella Franzen noted that the full-year outlook now factors in about 4% organic growth, including roughly 1% of pricing to offset higher input costs tied to the conflict in Iran.
Buyback and Segment Performance
DuPont also announced a $275 million accelerated share repurchase, set to launch immediately. This is part of a broader $2 billion buyback authorization the board approved in November, which included a $500 million accelerated tranche.
On the segment level, Healthcare & Water Technologies grew sales 6% year over year, with profit margins expanding 1.1 percentage points. The Diversified Industrials segment posted 3% sales growth, also with a 1.1 percentage point margin improvement.
DD stock had been down roughly 9% since the start of the Iran war on February 28, as investors weighed the effect of higher oil prices on input costs. Coming into Tuesday, the stock was still up 13% year to date and 66% over the past 12 months.
The Q2 outlook of 59 cents adjusted EPS on $1.8 billion in sales is the company’s most recent forward-looking data point.
🚨 Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
